WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, announced today that the Company will report its third quarter 2007 financial results after the U.S. Financial Markets close on Thursday, October 25, 2007. Following the announcement, Panacos will hold a conference call to discuss the results and provide an update on the Company’s development programs. Alan W. Dunton, M.D., Chief Executive Officer will host the call.
